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Abstract: Arthrofibrosis after total knee arthroplasty (TKA) is difficult to treat, as its aetiology remains unclear. In a 
previous study, we established a connection between the BMP-2 concentration in the synovial fluid and arthrofibrosis 
after TKA. The hypothesis of the present study was, therefore, that the limited range of motion in arthrofibrosis is caused 
by BMP-2 induced heterotopic ossifications, the quantity of which is dependent on the BMP-2 concentration in the 
synovial fluid. 
Eight patients with arthrofibrosis after TKA were included. The concentration of BMP-2 in the synovial fluid from each 
patient was determined by ELISA. Radiologically, digital radiographs were evaluated and the grey scale values were 
determined as a measure of the tissue density of defined areas. Apart from air, cutis, subcutis and muscle, the soft-tissue 
density in the area of the capsule of the suprapatellar pouch was determined. The connection between the BMP-2 
concentration and the soft-tissue density was then investigated. 
The average BMP-2 concentration in the synovial fluid was 24.3 ± 6.9 pg/ml. The density of the anterior knee capsule was 
on average 136 ± 35 grey scale values. A linear correlation was shown between the BMP-2 concentration in the synovial 
fluid and the radiological density of the anterior joint capsule (R=0.84, p = 0.009). 
We were able to show that there is a connection between BMP-2 concentration and soft-tissue density in arthrofibrosis 
after TKA. This opens up the possibility of conducting a prophylaxis against arthrofibrosis in risk patients by influencing 
the BMP-2 pathway. 
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INTRODUCTION 
  Arthrofibrosis after total knee arthroplasty (TKA), the 
incidence of which is reported as 3-10% in the literature [1-
4], remains an unsolved problem. As a result of the 
permanent painful limited range of motion, many patients 
experience a pronounced functional impairment of the 
affected knee, despite the TKA having been implanted 
correctly. Although risk factors such as the preoperative 
range of motion, previous surgery or diabetes mellitus are 
identified [3-5], the precise aetiology has remained unclear 
to date [3, 6-8]. This means that therapy can only be 
symptom-oriented at present, ranging from arthroscopic and 
open arthrolysis to revision arthroplasty [2, 3, 9, 10]. 
However, regardless of the procedure used, the results are 
largely unsatisfactory [3, 9]. 
  Without a clear pathomechanism, it has not been possible 
to develop a prophylaxis against arthrofibrosis up to now. 
However, cytokines in the synovial fluid, in particular bone 
morphogenetic protein 2 (BMP-2), appear to play a central 
role in the pathogenesis of arthrofibrosis. In a previous 
study, we demonstrated elevated concentrations of BMP-2 in 
the synovial fluid in arthrofibrosis after TKA [11]. Apart   
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from its inflammatory effect, BMP-2 is known in particular 
as a potent inductor of heterotopic ossifications (HO) in 
tissue [12-15]. Not only fibrosis of the soft tissues but also 
an increased incidence of HO were thus observed in further 
studies on arthrofibrosis after TKA [1, 16-19]. 
  In the future, it might be possible to reduce HO in the 
periarticular soft tissue by influencing the BMP-2 pathway 
and thus provide a prophylaxis against arthrofibrosis in risk 
patients, comparable to the established ossification 
prophylaxis in hip arthroplasty [20, 21]. 
  The hypothesis in the present investigation was therefore 
that the limited flexion in arthrofibrosis after TKA is caused 
by HO in the anterior soft tissue, the quantity of which 
depends on the BMP-2 concentration in the synovial fluid. 
MATERIALS AND METHODOLOGY 
  Patients with primary arthrofibrosis after TKA were 
included in this retrospective study. All of the study patients 
are part of a patient population of a previous study on BMP-
2 expression in synoviocytes in patients with arthrofibrosis 
after TKA [11]. The study protocol was approved by the 
institutional review board and all patients gave their 
informed consent. Age, sex, side and period since primary 
implantation were documented for each patient. 
  Up to now, the literature has not included a uniform 
definition of arthrofibrosis after TKA [3]. In the present 
study protocol, arthrofibrosis was defined as a painful 200    The Open Orthopaedics Journal, 2012, Volume 6  Pfitzner et al. 
limitation of flexion < 90° and an extension deficit > 10°, 
according to the classification of Yercan [22]. A pain 
duration of at least 6 months since implantation, a resting 
pain of > 5 and a weight bearing pain of > 7 on a visual 
analogue scale (VAS) were also defined as inclusion criteria 
regarding pain. 
  If there were signs of secondary arthrofibrosis present 
like infection, loosening, instability, impingement or 
malalignment, these knees were excluded. In all patients the 
same diagnostic algorithm was used. Every patient was 
clinically investigated by the senior author. At this point 
instability in the coronal (collateral ligamants) or sagittal 
plane (PCL) was detected. After that whole leg standing a.p. 
radiographs and lateral radiographs for exclusion of 
loosening, component malalignment and static impingement 
due to component oversizing were performed in all cases. 
For exclusion of infection all patients received blood sample 
analysis for blood leukocyte count, CRP and ESR such as 
joint fluid aspiration with following microbiological testing 
(14 days incubation). A pathological finding in one or more 
investigation lead to the exclusion of the patient. 
  Joint fluid was collected via aspiration in all knees once 
during the study. A minimum of 5 ml of synovial fluid was 
immediately cryoconserved and stored at -20°C until 
examination. The measurement of the concentration of 
BMP-2 was performed with ELISA. 
BMP-2 ELISA 
  The "Quantikine BMP-2 Immunoassay Kit" was used for 
analysing the concentration of BMP-2 in the synovial fluid 
according to the manufacturer's protocol (R&D systems, 
Minnesota, USA). The technique of this assay is a 
quantitative sandwich enzyme immunoassay. Extinction was 
measured in a microplate reader at a wavelength of 450nm. 
Radiological Investigation 
  The lateral digital radiographs of each patient, which 
were done within the context of routine clinical diagnostics, 
were evaluated according to standardised procedures. Of the 
original 10 patients, 2 had to be subsequently excluded due 
to the lack of digital radiographs. The digital images of the 
remaining 8 patients were evaluated using image processing 
software (ImageJ 1.45l, Maryland, USA). The individual 
grey scale values of defined points were recorded as a 
measure for the density of the tissue [23]. 
  In order to examine the interindividual comparability of 
the images, the grey scale values of standardised measuring 
points (air, cutis, subcutis, gastrocnemius muscle) were first 
compared using the image processing software. 
  For qualitative assessment of the soft-tissue density in the 
joint capsule / HO, the grey scale values in the area of the 
joint capsule of the suprapatellar pouch were evaluated. This 
was done by measuring a “region of interest” with a defined 
measuring square of 24mm
2 (Fig. 1). 
Statistics 
  Descriptive statistics (mean, minimum, maximum and 
standard deviations) were calculated from the measured data. 
Correlation analysis was done with the Pearson test. P=0.05 
was defined as the level of significance. 
 
Fig. (1). Standard digital radiographs with region of interest 
measurement. 
RESULTS 
  The average age of the 5 male and 3 female patients 
included was 67.5 ± 9.4 years. The side distribution of left to 
right knees showed a ratio of 7:1. The duration since primary 
implantation was on average 26.6 ± 15.7 months. 
BMP-2 ELISA 
  The concentration of BMP-2 in the synovial fluid of the 
analysed patients with arthrofibrosis after TKA was 24.3 ± 
6.9 pg/ml. 
Radiological Investigation 
  The evaluation of the digital, lateral radiographs showed 
only slight differences in the grey scales of the reference 
tissue, so that the subsequent evaluation of the anterior soft 
tissues was possible without correction in the sense of a 
standardisation. The grey scale values of air were on average 
2 ± 1.4. The cutis showed average grey scale values of 10.9 
± 2.7, the subcutis 26.9 ± 8.4 and the gastrocnemius muscle 
69.8 ± 11.6 (Fig. 2). 
Correlation Analysis Between BMP-2 Concentration and 
Soft-Tissue Density 
  The grey scale values of the measuring square in the area 
of the anterior knee capsule were on average 136.2 ± 34.5. 
  In the correlation analysis, a close linear correlation was 
found between the concentration of BMP-2 in the synovial 
fluid and the grey scale values of the anterior joint capsule as 
a measure of tissue density (R=0.84, p = 0.009) (Fig. 3). 
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Fig. (2). Grey values of different measured tissues. 
DISCUSSION 
  In this investigation, we were able to show that there is a 
connection between BMP-2 concentration in the synovial 
fluid and soft-tissue density of the anterior joint capsule in 
patients with arthrofibrosis after TKA. Although this 
increased density could be differentiated radiologically   
(Fig. 4), it did not reach the density of bone, so that radio-
logically visible HO were not present in any of the cases. 
 
Fig. (3). Linear correlation between BMP-2 concentration and 
Density of the suprapatellar pouch. 
  This is consistent with the observations of Freeman et al. 
[17]. On the basis of micro-CT and histology of 
arthrofibrosis after TKA, they demonstrated mineralised 
areas in the soft tissue with a density equivalent to bone, 
which were not identifiable as ossifications in conventional 
radiographs. The authors suspected the cause to be the 
insufficient resolution of conventional radiographs to reveal 
the ossifications present. However, the amount of ectopic 
bone in the soft tissue correlated with the extent of the 
patients' limitation of range of motion [17]. This leads to the 
conclusion that HO may already be present histologically, 
with clinically relevant impairment of flexion, although they 
are not detectable in conventional radiographs. 
  In the pathogenesis of arthrofibrosis, the persistence of 
physiological inflammation leads to a transdifferentiation of 
fibroblasts [1, 7, 17, 24, 25], followed by fibrosis of the soft 
tissue [1, 18, 19, 26]. Within the context of this tissue 
transformation, further studies have demonstrated HO in 
arthrofibrosis [1, 16-19]. 
 
  A connection between BMP-2 concentration in the 
synovial fluid and HO in arthrofibrosis after TKA has not 
been described in the literature to date. 
 
Fig. (4). Radiodense soft tissue formation at the suprapatellar 
pouch. 
  In a previous study, we showed an elevated BMP-2 
concentration in the synovial fluid (24.3 ± 6.9 pg/mL) and 
upregulation of BMP-2 in the synoviocytes in arthrofibrosis 
after TKA. The control group of non-operated knees showed 
a significantly lower BMP-2 concentration of 5.9 ± 4.8 
pg/mL [11]. However, a “normal” range of BMP-2 
concentration in the synovial fluid has not been described 
before. 
  Apart from its proinflammatory function, BMP-2 is also 
a strong inductor of heterotopic ossifications [11-15]. In 
vitro, it causes the osteogenic differentiation of human 
mesenchymal stem cells [27]. Within the context of a 
prolonged inflammation in arthrofibrosis, BMP-2 may 
therefore induce these HO in the soft tissue [28]. 
Corresponding to this, the upregulation of BMP-2 and BMP-
9 has been shown in patients with HO after hip arthroplasty 
[29, 30]. 
  In clinical application, chronic painful inflammations 
with pronounced HO have been observed after the 
application of BMP-2 in spondylodeses [31-33] and in 
fracture healing [34]. 
  One limitation of the present study is the small number of 
cases, resulting from the low rate of primary arthrofibroses  
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after TKA without any secondary cause. This low number of 
patients corresponds to a low power of this study, i.e. it is 
not possible to exclude a correlation between BMP-2 and 
soft tissue density if it had not been detected. But based on 
the statistically significant correlation even the low number 
of patients is sufficient to show a link between BMP-2 and 
soft-tissue density. A further limitation of this study is the 
absence of histological examinations of the altered joint 
capsule tissue. This was not possible in retrospect, due to the 
retrospective design of the study. 
CONCLUSION 
  With the present study, we have shown a connection 
between the BMP-2 concentration in the synovial fluid and 
soft-tissue density in the area of the anterior joint capsule in 
arthrofibrosis after TKA. In the future, it may be possible to 
influence the BMP-2 pathway as an inductor of HO in risk 
patients as a prophylaxis against arthrofibrosis after TKA. 
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